Thyroid Cancer Patients’ Survey – UK Data
Thyroid Cancer Patients¡¯ Survey ¨C UK Data
Executive Summary
Most respondents sought help because they had noticed a lump or swelling in
their neck
The majority of respondents were not seen by a thyroid specialist when they
were suspected of having thyroid cancer
Less than half respondents said that they had been offered additional support
at the stage of diagnosis, that they had been given details of a patient support
organisation or that they had received clear written information about their
condition and its treatment
Over three quarters of respondents sought information from sources outside
the hospital. The internet and patient support organisations appeared to be
the most helpful sources
Voice problems and low blood calcium levels were each experienced by
almost half the respondents after surgery
Radioactive iodine treatment normally occurred between one and two months
after surgery
Over half respondents experienced tiredness as a result of hypothyroidism
Taste disturbance and dry mouth were each experienced by approximately
one third of respondents after radioactive iodine treatment
A minority of respondents were offered thyrogen, but almost all who took it
had it paid for by the NHS
Side effects were much less common from thyrogen than from withdrawal
Among those who had both withdrawal and thyrogen, there was an
overwhelming preference for thyrogen
Respondents who took thyrogen were more likely to return to their normal
range of activities within one month of radioactive iodine treatment
Receiving a cancer diagnosis was the most frequently identified ¡®worst point¡¯
of the cancer journey
More information about the disease, psychological support, introduction to
patient support groups and quicker access to test results were all identified by
approximately one third of respondents as steps that would have improved
their cancer journey
More recently diagnosed patients were more likely to have been provided with
clear written information about their disease, specialist support and
information about patient support organisations
Diagnosis
Of 276 patients responding to the survey, 58 (21.0%) were male and 218
(79.0%) were female. 28 (10.1%) had a family history of thyroid cancer. 7
(2.5%) had had genetic testing for thyroid cancer and 6 (2.2%) had blood
relatives who had had such testing.
1
The chart below shows that most people were aged 30-60 when they were
diagnosed with thyroid cancer:
Chart 1: Age at Diagnosis of Thyroid Cancer
The table below shows that the majority of respondents were completing the
questionnaire 1-5 years after they had been diagnosed:
Table 1: Length of Time Since Diagnosis of Thyroid cancer
Length of time
Less than 1 year
1-5 years
More than 5 years
Total
Frequency Percent
28
10.1
160
58.0
88
31.9
276
100.0
Respondents were asked why they had approached their doctor initially and gave
the following responses (more than one response could be given):
2
Table 2: Reason for Approaching Doctor
Reason for approaching doctor
Frequency (%)
Noticed lump or swelling in neck
Family member noticed lump or swelling in neck
Difficulty swallowing
Hoarse voice
Difficulty breathing
Imaging check for another reason
Check up (family history or routine)
Other
194 (70.3%)
51 (18.5%)
49 (17.8%)
30 (10.9%)
23 (8.3%)
15 (5.4%)
9 (3.3%)
40 (14.5%)
As the table below shows, just over one half of respondents were seen by a
specialist within four weeks of referral:
Table 3: Length of Time Waiting to See a Specialist Once Referred
Length of time
Less than 2 weeks
2 weeks - 4 weeks
4 weeks - 3 months
More than 3 months
I was seen immediately
Don¡¯t know
Total
Frequency Percent
52
18.8
94
34.1
86
31.2
31
11.2
4
1.4
9
3.3
276
100.0
However, in the majority of cases, the first specialist seen was not a thyroid
cancer specialist, as is shown below:
Table 4: First Specialist Seen
Specialist
Surgeon (general)
Endocrinologist
Endocrine Surgeon
Head and Neck Surgeon
Vascular Surgeon
Oncologist
Other
Total
Frequency Percent
116
42.0
36
13.0
43
15.6
54
19.6
4
1.4
6
2.2
17
6.2
276
100.0
The table below indicates that the majority of respondents were diagnosed within
four weeks of seeing a specialist:
3
Table 5: Time Between Getting Diagnosis and Seeing Specialist
Length of time
Less than 2 weeks
2 weeks - 4 weeks
More than 4 weeks
Don¡¯t know
Total
Frequency Percent
86
31.2
106
38.4
73
26.4
11
4.0
276
100.0
A small majority of respondents (141 or 51.1%) said that they had been given the
diagnosis by a thyroid cancer specialist, rather than another health professional.
However, there was some ambiguity in the responses to this question: 119
(43.1%) answered ¡®other¡¯, with common answers being endocrinologist, ENT
surgeons and surgeons. The large majority of respondents, 240 or 87%, were
told of the diagnosis in person at the hospital.
The most common diagnosis was papillary thyroid cancer, as is shown below:
Table 6: Type of Thyroid Cancer Diagnosed
Type
Papillary
Follicular
Mix papillary/follicular
types of thyroid cancer
Medullary
Hurthle Cell
Frequency Percent
144
52.2
41
14.9
21
7.6
Anaplastic
Don¡¯t know
Other
Total
17
9
6.2
3.3
5
31
8
276
1.8
11.2
2.9
100.0
Patient Support at Diagnosis
105 of the 276 respondents (38%) were offered additional support at the stage of
diagnosis from a specialist. 88 (31.9%) were given details of a patient support
organisation. 121 (43.8%) received clear written information about their condition
and its treatment.
216 respondents (78.3%) sought information from outside the hospital clinic. The
outside sources that were consulted are listed below (more than one could be
chosen by each respondent), together with the numbers saying that the source
was most helpful:
4
Table 7: Source of Information and Support Used And Their Helpfulness
Source of information
Number / per cent
Number / per
cent saying most
helpful
Internet
Pamphlets from thyroid cancer organisations
Patient support organizations
Books about thyroid cancer
Family doctor
Family and friends
Other patients / survivors
Complementary therapy
Other
172 (62.3%)
99 (35.9%)
63 (22.8%)
60 (21.7%)
55 (19.9%)
52 (18.8%)
46 (16.7%)
14 ( 5.1%)
21 ( 7.6%)
87 (31.5%)
30 (10.9%)
34 (12.3%)
7 (2.5%)
13 (4.7%)
7 (2.5%)
17 (6.2%)
0
13 (4.7%)
This suggests that the most helpful forms of additional information were the
internet and patient support organisations. Moderately helpful information
sources were pamphlets produced by thyroid cancer orgainsations and other
patients / survivors. Unhelpful sources were the family doctor, books, family and
friends and complementary therapies.
Surgery
Almost all respondents had experienced neck surgery, with a little more than half
having had two surgical procedures, as is shown in the table below:
Table 8: Number of Neck Surgeries for Thyroid Cancer
Number of
Surgeries
0
1
2
3
4
5
Total
Frequency Percent
3
1.1
98
35.5
148
53.6
19
6.9
7
2.5
1
.4
276
100.0
65 respondents (23.6%) did not experience any post surgery complications. The
frequency with which specific complications occurred is shown in the table below:
5
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- s p o h n c
- tips for managing thick saliva or mucous
- side effects of high dose radioactive iodine for ablation
- oral manifestations of endocrine disorders
- does lemon candy decrease salivary gland damage after
- head and neck radiation treatment and your mouth
- if you have thyroid cancer
- radiotherapy side effects and management thyroid cancer
- now approved mayo
- after laryngeal and hypopharyngeal cancer treatment
Related searches
- survey curve data calculator
- thyroid cancer in dogs
- thyroid cancer ultrasound colors
- symptoms thyroid cancer has spread
- thyroid cancer radiation therapy
- thyroid cancer image
- life after thyroid cancer removal
- pneumonia in cancer patients prognosis
- symptoms of thyroid cancer in women
- thyroid cancer after thyroid removed
- thyroid cancer treatment after surgery
- is thyroid cancer deadly